UPDATE 1-Sequenom to cut jobs; seeks liquid biopsy test partners

Jan 7 (Reuters) - Genetic testing company Sequenom Inc said on Thursday it will cut 110 jobs, or about 20 percent of its workforce, and will seek partners to commercialize its liquid biopsy test.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.